LEXARIA BIOSCIENCE CORP. Operating Lease Right-of-Use Assets
LEXARIA BIOSCIENCE CORP. (LEXX) had Operating Lease Right-of-Use Assets of $84.42 thousand as of 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-07-13
- 2026-05-31: Operating Lease, Right-of-Use Asset $84.42K.
- 2025-08-31: Operating Lease, Right-of-Use Asset $106.82K; Operating Lease, Right-of-Use Asset as first filed $134.84K.
- 2025-05-31: Operating Lease, Right-of-Use Asset $156.75K.
- 2025-02-28: Operating Lease, Right-of-Use Asset $156.75K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-05-31 | $84.42K 10-Q · filed 2026-07-13 | |
| 2025-08-31 | $106.82K 10-Q · filed 2026-07-13 | $134.84K 10-K · filed 2025-11-28 |
| 2025-05-31 | $156.75K 10-Q · filed 2025-07-14 | |
| 2025-02-28 | $156.75K 10-Q · filed 2025-04-14 | |
| 2024-08-31 | $167.45K 10-K · filed 2025-11-28 | |
| 2024-05-31 | $143.32K 10-Q · filed 2024-07-12 | |
| 2024-02-29 | $150.00K 10-Q · filed 2024-04-09 | |
| 2023-08-31 | $167.45K 10-Q · filed 2024-07-12 | |
| 2022-05-31 | $62.36K 10-Q · filed 2022-07-14 | |
| 2022-02-28 | $72.10K 10-Q · filed 2022-04-11 | |
| 2021-11-30 | $81.66K 10-Q · filed 2022-01-14 | |
| 2021-08-31 | $91.04K 10-Q · filed 2022-07-14 | |
| 2021-05-31 | $100.26K 10-Q · filed 2021-07-15 | |
| 2021-02-28 | $109.31K 10-Q · filed 2021-04-14 | |
| 2020-11-30 | $118.19K 10-Q · filed 2021-01-14 | |
| 2020-08-31 | $126.92K 10-Q · filed 2021-07-15 | |
| 2019-09-01 | $160.29K 10-K · filed 2021-11-29 | |
| 2019-08-31 | $0.00 10-K · filed 2020-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |